Company Performance - UnitedHealth Group (UNH) closed at 7.27, reflecting a 5.21% increase year-over-year [2] - The consensus estimate for revenue is 29.63 per share and revenue at $451.2 billion, representing increases of +7.12% and +12.72% respectively from the previous year [3] Analyst Forecasts - Recent revisions to analyst forecasts for UnitedHealth Group are important as they reflect short-term business trends, with positive revisions indicating optimism about the company's outlook [4] Stock Performance Correlation - Empirical research shows a direct correlation between estimate revisions and stock price performance, which is utilized in the Zacks Rank model to provide operational ratings [5] Zacks Rank - UnitedHealth Group currently holds a Zacks Rank of 3 (Hold), with the consensus EPS estimate remaining unchanged over the last 30 days [6] Valuation Metrics - The company has a Forward P/E ratio of 17.4, which is a premium compared to the industry's average Forward P/E of 14.91 [7] - UnitedHealth Group's PEG ratio stands at 1.4, compared to the Medical - HMOs industry's average PEG ratio of 1.13 [7] Industry Context - The Medical - HMOs industry is ranked 206 in the Zacks Industry Rank, placing it in the bottom 18% of over 250 industries [8]
UnitedHealth Group (UNH) Rises As Market Takes a Dip: Key Facts